Dianthus Therapeutics (DNTH) Misses Q2 EPS by 51c
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Join SI Premium – FREE
Dianthus Therapeutics (NASDAQ: DNTH) reported Q2 EPS of ($0.51).
For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Appeals court allows Trump administration to expand fast-track deportation process
- US sanctions Cuban military bank and mining company
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
